This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Austin, S. et al. JAMA 268, 516–519 (1992).
Cartmell, T. et al. J. Physiol. 549, 653–664 (2003).
Leday, G.R.G. et al. Biol. Psychiatry http://dx.doi.org/10.1016/j.biopsych.2017.01.021 (2017).
Dowlati, Y. et al. Biol. Psychiatry 67, 446–457 (2010).
Zhu, C.B., Blackely, R.D. & Hewlett, W.A. Neuropsychopharmacology 31, 2121–2131 (2006).
Pasco, J. et al. Br. J. Psychiatry 197, 372–377 (2010).
Khandaker, G.M. et al. JAMA Psychiatry 71,1121–1128 (2014).
Valentine, A.D. et al. Sem. Oncol. 25, 39–47 (1998).
Ridker, P.M. Cir. Res. 118, 145–156 (2016).
Raison, C.L. et al. JAMA Psychiatry 70, 31–41 (2013).
Powel, T.R. et al. Eur. Neuropsychopharmacol. 23, 1105–1114 (2013).
Catteneo, A. et al. Int. J. Neuropsychopharmacol. 19, pyw045 (2016).
Author information
Author notes
Nicole Wetsman is Nature Medicine's news intern in New York.
- Nicole Wetsman
Rights and permissions
About this article
Cite this article
Wetsman, N. Inflammatory illness: Why the next wave of antidepressants may target the immune system. Nat Med 23, 1009–1011 (2017). https://doi.org/10.1038/nm0917-1009
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0917-1009